|
Volumn 47, Issue 17, 2011, Pages 2512-2516
|
Tumour growth rates and RECIST criteria in early drug development
|
Author keywords
Early phase clinical trials; New drugs; Pre treatment growth rate; RECIST; Stable disease; Tumour evaluation; Tumour growth dynamics; Tumour growth kinetics
|
Indexed keywords
ADULT;
ARTICLE;
CANCER GROWTH;
CLINICAL EVALUATION;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED STUDY;
DRUG DEVELOPMENT;
EXPERIMENTAL DESIGN;
FEMALE;
GROWTH ACCELERATION;
GROWTH RATE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PREMEDICATION;
PRIORITY JOURNAL;
TREATMENT DURATION;
TREATMENT RESPONSE;
CLINICAL TRIALS, PHASE I AS TOPIC;
DISEASE PROGRESSION;
FEASIBILITY STUDIES;
FEMALE;
HUMANS;
MALE;
NEOPLASMS;
TUMOR BURDEN;
|
EID: 80755139581
PISSN: 09598049
EISSN: 18790852
Source Type: Journal
DOI: 10.1016/j.ejca.2011.06.012 Document Type: Article |
Times cited : (79)
|
References (4)
|